AL
CVS icon

Aspiriant LLC’s CVS Health CVS Stock Holding History

Aspiriant LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,287
Closed -$262K – 297
2024
Q1 		$262K Sell
3,287
-380
-10% -$29K 0.01% 275
2023
Q4 		$290K Sell
3,667
-728
-17% -$51.8K 0.01% 245
2023
Q3 		$307K Buy
4,395
+844
+24% +$59.8K 0.02% 218
2023
Q2 		$245K Sell
3,551
-12
-0.3% -$854 0.01% 250
2023
Q1 		$265K Sell
3,563
-58
-2% -$4.86K 0.01% 231
2022
Q4 		$337K Buy
3,621
+260
+8% +$25.1K 0.02% 205
2022
Q3 		$321K Buy
3,361
+633
+23% +$62.7K 0.02% 205
2022
Q2 		$253K Sell
2,728
-89
-3% -$8.69K 0.01% 231
2022
Q1 		$286K Buy
2,817
+708
+34% +$74.4K 0.02% 229
2021
Q4 		$218K Buy
+2,109
New +$195K 0.01% 261
2020
Q1 		– Sell
-2,744
Closed -$204K – 195
2019
Q4 		$204K Sell
2,744
-1,275
-32% -$89.5K 0.02% 196
2019
Q3 		$253K Sell
4,019
-960
-19% -$56.9K 0.02% 192
2019
Q2 		$271K Sell
4,979
-778
-14% -$41.9K 0.02% 191
2019
Q1 		$310K Sell
5,757
-1,726
-23% -$107K 0.03% 178
2018
Q4 		$492K Sell
7,483
-1,872
-20% -$140K 0.04% 144
2018
Q3 		$736K Sell
9,355
-2,159
-19% -$154K 0.06% 125
2018
Q2 		$741K Sell
11,514
-1,785
-13% -$118K 0.06% 131
2018
Q1 		$827K Buy
13,299
+10,376
+355% +$744K 0.07% 120
2017
Q4 		$212K Sell
2,923
-21,197
-88% -$1.54M 0.06% 78
2017
Q3 		$1.96M Sell
24,120
-5,325
-18% -$421K 0.16% 78
2017
Q2 		$2.37M Sell
29,445
-2,609
-8% -$206K 0.21% 70
2017
Q1 		$2.52M Sell
32,054
-269
-0.8% -$21.5K 0.21% 73
2016
Q4 		$2.55M Sell
32,323
-1,100
-3% -$89K 0.23% 63
2016
Q3 		$2.97M Sell
33,423
-2,186
-6% -$206K 0.3% 51
2016
Q2 		$3.73M Sell
35,609
-1,020
-3% -$102K 0.35% 47
2016
Q1 		$3.8M Buy
+36,629
New +$3.56M 0.36% 42

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Aspiriant LLC's CVS Position: Q2 2024 in Review

Aspiriant LLC sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,287 shares — an estimated $262K sold.

Aspiriant LLC first reported a position in CVS in Q1 2016 and held it in 26 quarters. The position peaked at $3.8M in Q1 2016. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Aspiriant LLC reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 3,287 CVS Health shares in Q2 2024, an estimated $262K.
  • Aspiriant LLC first reported a position in CVS Health in Q1 2016 and held it in 26 quarters.
  • Aspiriant LLC's CVS Health position peaked at $3.8M in Q1 2016.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.